by |

Japanese homegrown COVID-19 vaccine will become available in early 2022

5 1 vote
Article Rating

Daiichi Sankyo’s COVID-19 vaccine is in the Phase 3 trials and will become available in March 2022 if everything goes well.

Screenshot of asia.nikkei.com

https://asia.nikkei.com/Spotlight/Coronavirus/Japan-nears-homegrown-vaccine-with-Daiichi-Sankyo-Phase-3-trials

Subscribe
Notify of
0 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments